Skip to main content

Advertisement

Log in

Defining Cure for Esophageal Cancer: Analysis of Actual 5-Year Survivors Following Esophagectomy

  • Thoracic Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Esophagectomy is the mainstay of curative treatment for localized esophageal cancer. However, what constitutes cure is not well defined. This study was undertaken to characterize actual 5-year survivors following esophagectomy and to determine prognostic factors for disease-specific survival (DSS) from 60 months.

Materials and Methods

Between 1987 and 2004, 398 consecutive patients underwent esophagectomy and had potential for 5 years follow-up. Clinicopathological factors associated with DSS from 5 years onward were analyzed.

Results

Median DSS was 25 months. Neoadjuvant therapy was administered to 159 of 398 (40%). There were 114 of 398 (29%) actual 5-year survivors. On multivariate analysis, 5-year survivors were significantly more likely to have lower T classification, N classification, and R0 resections compared with patients who died less than 5 years after surgery. There were 66 of 398 patients (17%) with positive margins, and 6 of these were 5-year survivors. Of the 114 5-year survivors, 17 (15%) subsequently died of esophageal cancer. Prognostic factors for DSS after surviving 5 years were age and T classification for patients treated with neoadjuvant therapy and surgery alone, respectively. Powerful prognostic factors from time of treatment, including nodal status, were no longer prognostic factors after surviving to 5 years.

Conclusions

No single clinicopathological variable negated survival to 5 years. Prognostication once surviving 5 years is difficult. The majority of 5-year survivors can be considered cured of esophageal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Law S, Kwong DL, Kwok KF, Wong KH, Chu KM, Sham JS, et al. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg. 2003;238:339–347; discussion 347–8.

    PubMed  Google Scholar 

  2. Stein HJ, von Rahden BH, Siewert JR. Survival after oesophagectomy for cancer of the oesophagus. Langenbecks Arch Surg. 2005;390:280–5.

    Article  PubMed  Google Scholar 

  3. Hofstetter W, Swisher SG, Correa AM, Hess K, Putnam JB Jr, Ajani JA, et al. Treatment outcomes of resected esophageal cancer. Ann Surg. 2002;236:376–85.

    Article  PubMed  Google Scholar 

  4. Pohl H, Welch G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142–6.

    Article  PubMed  Google Scholar 

  5. Blot W, Devesa S, Kneller R, Fraumeni J. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287–9.

    Article  PubMed  CAS  Google Scholar 

  6. Jemal A, Siegel R, Ward E. Cancer statistics. CA Cancer J Clin. 2007;57:43–66.

    Article  PubMed  Google Scholar 

  7. Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg. 2001;234:520–30; discussion 530–1.

    Article  PubMed  CAS  Google Scholar 

  8. Altorki NK, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg. 2002;236:177–83.

    Article  PubMed  Google Scholar 

  9. Watson A. Operable esophageal cancer: Current results from the West. World J Surg. 1994;18:361–6.

    Article  PubMed  CAS  Google Scholar 

  10. Portale G, Hagen JA, Peters JH, Chan LS, DeMeester SR, Gandamihardja TA, et al. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg. 2006;202:588–96; discussion 596–8.

    Article  PubMed  Google Scholar 

  11. Hulscher JB. Transthoracic versus transhiatal resection for carcinoma of the esophagus: A meta-analysis. Ann Thorac Surg. 2001;72:306–13.

    Article  PubMed  CAS  Google Scholar 

  12. Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, et al. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg. 2005;189:98–109.

    Article  PubMed  Google Scholar 

  13. Green FL, Page DL, Fleming ID. AJCC cancer staging manual. New York, NY: Springer-Verlag, 2002.

    Book  Google Scholar 

  14. Barbour AP, Jones M, Gonen M, Gotley DC, Thomas J, Thomson DB, et al. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response. Ann Surg Oncol. 2008;15:2894–902.

    Article  PubMed  Google Scholar 

  15. Siewert JR, Stein HJ, Feith M, Bruecher BLDM, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: Lessons from more than 1000 consecutive resections at a single center in the Western world. Ann Surg. 2001;234:360–9.

    Article  PubMed  CAS  Google Scholar 

  16. Dubecz A, Molena D, Peters, JH. Modern surgery for esophageal cancer. Gastroenterol Clin North Am. 2008;37:965–87.

    Article  Google Scholar 

  17. Peyre CG, Hagen JA, DeMeester SR, Altorki NK, Ancona E, Griffin SM, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248:549–56.

    Article  PubMed  Google Scholar 

  18. Siewert JR, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction. Ann Surg. 2000;232:353–61.

    Article  Google Scholar 

  19. Smithers BM, Gotley DC, Martin I, Thomas JM. Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg. 2007;245:–232–40.

    Article  PubMed  Google Scholar 

  20. Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol. 2003;4:481–8.

    Article  PubMed  Google Scholar 

  21. Leibman S, Smithers BM, Gotley DC, Martin I, Thomas J. Minimally invasive esophagectomy: short- and long-term outcomes. Surg Endosc. 2006;20:428–33.

    Article  PubMed  CAS  Google Scholar 

  22. Sutton DN, Wayman J, Griffin SM. Learning curve for oesophageal cancer surgery. Br J Surg. 1998;85:1399–402.

    Article  PubMed  CAS  Google Scholar 

  23. Burmeister B, Smithers BM, Gebski V. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol. 2006;6:659–68.

    Article  Google Scholar 

  24. Conlon KC, Klimstra MD, Brennan M. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Ann Surg. 1996;223:273–9.

    Article  PubMed  CAS  Google Scholar 

  25. Hochwald SN, Kim S, Klimstra MD, Brennan MF, Karpeh MS. Analysis of 154 actual five-year survivors of gastric cancer. J Gastrointest Surg. 2000;4:520–5.

    Article  PubMed  CAS  Google Scholar 

  26. Vorburger SA, Ubersax L, Schmid SW, Balli M, Candinas D, Seiler CA. Long-term follow-up after complete resection of well-differentiated cancer confined to the thyroid gland. Ann Surg Oncol. 2009;16:2862–74.

    Article  PubMed  Google Scholar 

  27. Karakiewicz PI, Jeldres C, Suardi N, Hutterer GC, Perrotte P, Capitanio U, et al. Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy. Can Urol Assoc J. 2008;2:610–7.

    PubMed  Google Scholar 

  28. Zhang DW, Cheng GY, Huang GJ, Zhang RG, Liu XY, Mao YS, et al. Operable squamous esophageal cancer: current results from the East. World J Surg. 1994;18:347–54.

    Article  PubMed  CAS  Google Scholar 

  29. Omundsen M, Babor R, Johnston P. Outcomes after oesophagogastrectomy for carcinoma of the oesophagus. ANZ J Surg. 2007;77:37–9.

    Article  PubMed  Google Scholar 

  30. Tomlinson J, Jarnagin W, DeMatteo R, Fong Y, Kornprat P, Gonen M, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;25:4575–80.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

We would like to thank Dr. Ian Martin for his clinical contributions and recruitment of patients. Research funding: Paul Mackay Bolton Scholarship 2009, Royal Australasian College of Surgeons.

Financial Disclosure

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew Barbour PhD, MBBS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hirst, J., Smithers, B.M., Gotley, D.C. et al. Defining Cure for Esophageal Cancer: Analysis of Actual 5-Year Survivors Following Esophagectomy. Ann Surg Oncol 18, 1766–1774 (2011). https://doi.org/10.1245/s10434-010-1508-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1508-z

Keywords

Navigation